Results
181
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
181 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
CRDO | US$33.09 | 4.1% | 97.1% | US$5.1b | US$29.83 | PS28.3x | E60.9% | n/a | Semiconductors | ||
EH | US$15.42 | 7.2% | -20.0% | US$998.6m | US$24.98 | PS45.1x | E74.3% | n/a | Capital Goods | ||
ATAT | US$18.09 | -3.9% | -7.2% | US$2.6b | US$27.17 | PE18.5x | E22.1% | 0.8% | Consumer Services | ||
VCTR | US$52.16 | 10.6% | 56.6% | US$3.3b | US$52.00 | PE15.4x | E33.6% | 2.8% | Diversified Financials | ||
TBBB | US$25.05 | 2.3% | n/a | US$2.8b | US$26.84 | PS1.1x | E94.7% | n/a | Consumer Retailing | ||
PDD | US$137.99 | 2.5% | 74.5% | US$197.8b | US$205.61 | PE17.4x | E23.3% | n/a | Retail | ||
GCT | US$29.69 | -5.3% | 262.1% | US$1.2b | US$52.33 | PE11.6x | E21.3% | n/a | Retail | ||
CG | US$44.07 | 8.8% | 29.4% | US$15.6b | US$48.05 | PS7.1x | E23.6% | 3.2% | Diversified Financials | ||
SMCI | US$897.68 | -0.2% | 197.2% | US$53.3b | US$1,032.47 | PE50.1x | E40.1% | n/a | Tech | ||
BRDG | US$8.19 | 13.0% | -35.5% | US$975.1m | US$9.88 | PS1x | E98.2% | 8.1% | Diversified Financials | ||
DUOL | US$192.05 | -2.4% | 21.2% | US$8.2b | US$252.23 | PE181.6x | E48.1% | n/a | Consumer Services | ||
ZKH | US$3.66 | -4.7% | n/a | US$613.7m | US$15.74 | PB1.3x | E104.4% | n/a | Capital Goods | ||
MAX | US$13.65 | 8.0% | 42.5% | US$842.8m | US$25.33 | PS1.7x | E88.1% | n/a | Media | ||
CARG | US$26.18 | 4.8% | 10.3% | US$2.6b | US$26.85 | PE75.2x | E29.2% | n/a | Media | ||
HOFV | US$2.97 | -2.3% | -71.0% | US$19.7m | US$8.00 | PB0.2x | E71.1% | n/a | Consumer Services | ||
HNVR | US$16.85 | 3.7% | -6.7% | US$119.7m | US$18.50 | PB0.6x | E20.9% | 2.4% | Banks | ||
EVOK | US$0.59 | 9.3% | -65.1% | US$5.0m | US$7.00 | PB1.5x | E110.6% | n/a | Pharmaceuticals & Biotech | ||
NEON | US$2.41 | 1.3% | -46.3% | US$35.9m | US$3.00 | PS8.8x | E158.0% | n/a | Tech | ||
SPRY | US$11.66 | 23.0% | 68.0% | US$1.1b | US$19.00 | PS112979.9x | E57.7% | n/a | Pharmaceuticals & Biotech | ||
SMSI | US$2.37 | 5.3% | -75.7% | US$24.2m | US$10.67 | PB0.6x | E81.8% | n/a | Software | ||
CBNK | US$22.49 | 12.3% | 19.9% | US$299.8m | US$26.38 | PB1.2x | E27.5% | 1.4% | Banks | ||
MYO | US$5.00 | 22.9% | 523.9% | US$132.3m | US$6.80 | PS7.4x | E64.4% | n/a | Healthcare | ||
ALKT | US$31.65 | 4.0% | 88.4% | US$3.0b | US$30.10 | PS11x | E92.1% | n/a | Software | ||
MDGL | US$279.95 | -3.7% | 25.5% | US$6.1b | US$365.07 | PB7x | E63.8% | n/a | Pharmaceuticals & Biotech |